vs

Side-by-side financial comparison of INTERNATIONAL BANCSHARES CORP (IBOC) and Pennant Group, Inc. (PNTG). Click either name above to swap in a different company.

Pennant Group, Inc. is the larger business by last-quarter revenue ($289.3M vs $217.7M, roughly 1.3× INTERNATIONAL BANCSHARES CORP). INTERNATIONAL BANCSHARES CORP runs the higher net margin — 62.3% vs 3.0%, a 59.3% gap on every dollar of revenue. On growth, Pennant Group, Inc. posted the faster year-over-year revenue change (53.2% vs 4.5%). INTERNATIONAL BANCSHARES CORP produced more free cash flow last quarter ($472.9M vs $17.4M). Over the past eight quarters, Pennant Group, Inc.'s revenue compounded faster (35.8% CAGR vs 2.8%).

International Bancshares Corporation is a bank holding company based in Laredo, Texas whose primary subsidiary is International Bank of Commerce. Through its bank subsidiaries, it has 217 banking offices and 315 automated teller machines serving 88 communities in the U.S. states of Texas and Oklahoma.

The Pennant Group, Inc. is a U.S.-headquartered healthcare services provider that delivers home health care, hospice services, senior living solutions, and skilled nursing support. It operates across dozens of U.S. states, serving primarily elderly and medically vulnerable populations through its network of localized care facilities.

IBOC vs PNTG — Head-to-Head

Bigger by revenue
PNTG
PNTG
1.3× larger
PNTG
$289.3M
$217.7M
IBOC
Growing faster (revenue YoY)
PNTG
PNTG
+48.6% gap
PNTG
53.2%
4.5%
IBOC
Higher net margin
IBOC
IBOC
59.3% more per $
IBOC
62.3%
3.0%
PNTG
More free cash flow
IBOC
IBOC
$455.5M more FCF
IBOC
$472.9M
$17.4M
PNTG
Faster 2-yr revenue CAGR
PNTG
PNTG
Annualised
PNTG
35.8%
2.8%
IBOC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IBOC
IBOC
PNTG
PNTG
Revenue
$217.7M
$289.3M
Net Profit
$106.9M
$8.6M
Gross Margin
Operating Margin
62.8%
6.0%
Net Margin
62.3%
3.0%
Revenue YoY
4.5%
53.2%
Net Profit YoY
-7.1%
50.0%
EPS (diluted)
$1.71
$0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IBOC
IBOC
PNTG
PNTG
Q4 25
$217.7M
$289.3M
Q3 25
$218.1M
$229.0M
Q2 25
$208.2M
$219.5M
Q1 25
$198.2M
$209.8M
Q4 24
$208.3M
$188.9M
Q3 24
$211.8M
$180.7M
Q2 24
$207.8M
$168.7M
Q1 24
$205.8M
$156.9M
Net Profit
IBOC
IBOC
PNTG
PNTG
Q4 25
$106.9M
$8.6M
Q3 25
$108.4M
$6.1M
Q2 25
$100.1M
$7.1M
Q1 25
$96.9M
$7.8M
Q4 24
$115.1M
$5.8M
Q3 24
$99.8M
$6.2M
Q2 24
$97.0M
$5.7M
Q1 24
$97.3M
$4.9M
Operating Margin
IBOC
IBOC
PNTG
PNTG
Q4 25
62.8%
6.0%
Q3 25
62.6%
4.5%
Q2 25
60.5%
5.3%
Q1 25
61.1%
6.0%
Q4 24
64.2%
4.9%
Q3 24
60.0%
6.0%
Q2 24
60.1%
5.7%
Q1 24
59.9%
5.4%
Net Margin
IBOC
IBOC
PNTG
PNTG
Q4 25
62.3%
3.0%
Q3 25
49.7%
2.7%
Q2 25
48.1%
3.2%
Q1 25
48.9%
3.7%
Q4 24
71.5%
3.0%
Q3 24
47.1%
3.4%
Q2 24
46.7%
3.4%
Q1 24
47.3%
3.1%
EPS (diluted)
IBOC
IBOC
PNTG
PNTG
Q4 25
$1.71
$0.25
Q3 25
$1.74
$0.17
Q2 25
$1.61
$0.20
Q1 25
$1.56
$0.22
Q4 24
$1.85
$0.16
Q3 24
$1.60
$0.20
Q2 24
$1.56
$0.18
Q1 24
$1.56
$0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IBOC
IBOC
PNTG
PNTG
Cash + ST InvestmentsLiquidity on hand
$5.5B
Total DebtLower is stronger
$168.8M
Stockholders' EquityBook value
$3.3B
$374.3M
Total Assets
$16.6B
$968.2M
Debt / EquityLower = less leverage
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IBOC
IBOC
PNTG
PNTG
Q4 25
$5.5B
Q3 25
$5.6B
Q2 25
$5.8B
Q1 25
$5.6B
Q4 24
$5.4B
Q3 24
$5.8B
Q2 24
$5.7B
Q1 24
$5.7B
Total Debt
IBOC
IBOC
PNTG
PNTG
Q4 25
$168.8M
Q3 25
$26.0M
Q2 25
$37.0M
Q1 25
$52.5M
Q4 24
$0
Q3 24
$108.9M
Q2 24
$82.2M
Q1 24
$83.3M
Stockholders' Equity
IBOC
IBOC
PNTG
PNTG
Q4 25
$3.3B
$374.3M
Q3 25
$3.1B
$343.0M
Q2 25
$3.0B
$333.6M
Q1 25
$2.9B
$323.0M
Q4 24
$2.8B
$312.0M
Q3 24
$2.7B
$187.3M
Q2 24
$2.6B
$173.0M
Q1 24
$2.5B
$164.2M
Total Assets
IBOC
IBOC
PNTG
PNTG
Q4 25
$16.6B
$968.2M
Q3 25
$16.6B
$753.6M
Q2 25
$16.5B
$751.4M
Q1 25
$16.3B
$743.6M
Q4 24
$15.7B
$679.5M
Q3 24
$15.9B
$646.8M
Q2 24
$15.5B
$602.5M
Q1 24
$15.4B
$578.2M
Debt / Equity
IBOC
IBOC
PNTG
PNTG
Q4 25
0.45×
Q3 25
0.08×
Q2 25
0.11×
Q1 25
0.16×
Q4 24
0.00×
Q3 24
0.58×
Q2 24
0.48×
Q1 24
0.51×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IBOC
IBOC
PNTG
PNTG
Operating Cash FlowLast quarter
$491.1M
$21.0M
Free Cash FlowOCF − Capex
$472.9M
$17.4M
FCF MarginFCF / Revenue
217.2%
6.0%
Capex IntensityCapex / Revenue
8.3%
1.2%
Cash ConversionOCF / Net Profit
4.59×
2.43×
TTM Free Cash FlowTrailing 4 quarters
$809.9M
$36.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IBOC
IBOC
PNTG
PNTG
Q4 25
$491.1M
$21.0M
Q3 25
$115.2M
$13.9M
Q2 25
$95.5M
$34.6M
Q1 25
$140.5M
$-21.2M
Q4 24
$473.9M
$20.6M
Q3 24
$116.5M
$7.7M
Q2 24
$107.2M
$10.5M
Q1 24
$135.4M
$545.0K
Free Cash Flow
IBOC
IBOC
PNTG
PNTG
Q4 25
$472.9M
$17.4M
Q3 25
$112.2M
$10.5M
Q2 25
$91.6M
$31.6M
Q1 25
$133.1M
$-23.2M
Q4 24
$459.8M
$17.2M
Q3 24
$109.6M
$6.8M
Q2 24
$104.9M
$8.9M
Q1 24
$128.9M
$-2.6M
FCF Margin
IBOC
IBOC
PNTG
PNTG
Q4 25
217.2%
6.0%
Q3 25
51.5%
4.6%
Q2 25
44.0%
14.4%
Q1 25
67.1%
-11.1%
Q4 24
220.8%
9.1%
Q3 24
51.7%
3.8%
Q2 24
50.5%
5.3%
Q1 24
62.6%
-1.7%
Capex Intensity
IBOC
IBOC
PNTG
PNTG
Q4 25
8.3%
1.2%
Q3 25
1.3%
1.5%
Q2 25
1.9%
1.4%
Q1 25
3.7%
0.9%
Q4 24
6.8%
1.8%
Q3 24
3.3%
0.5%
Q2 24
1.1%
1.0%
Q1 24
3.2%
2.0%
Cash Conversion
IBOC
IBOC
PNTG
PNTG
Q4 25
4.59×
2.43×
Q3 25
1.06×
2.29×
Q2 25
0.95×
4.89×
Q1 25
1.45×
-2.73×
Q4 24
4.12×
3.57×
Q3 24
1.17×
1.24×
Q2 24
1.11×
1.84×
Q1 24
1.39×
0.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IBOC
IBOC

Segment breakdown not available.

PNTG
PNTG

Home Health Subsegment$136.2M47%
Hospice Subsegment$97.1M34%
Private And Other$36.4M13%
Medicare And Medicaid$19.6M7%
Affiliated Entity$2.2M1%

Related Comparisons